Issue 16, 2018

Asymmetric mesoporous silica nanoparticles as potent and safe immunoadjuvants provoke high immune responses

Abstract

Asymmetric mesoporous silica nanoparticles with a head–tail structure are potent immunoadjuvants for delivering a peptide antigen, generating a higher antibody immune response in mice compared to their symmetric counterparts.

Graphical abstract: Asymmetric mesoporous silica nanoparticles as potent and safe immunoadjuvants provoke high immune responses

Supplementary files

Article information

Article type
Communication
Submitted
15 Jan 2018
Accepted
29 Jan 2018
First published
29 Jan 2018

Chem. Commun., 2018,54, 2020-2023

Asymmetric mesoporous silica nanoparticles as potent and safe immunoadjuvants provoke high immune responses

P. L. Abbaraju, M. Jambhrunkar, Y. Yang, Y. Liu, Y. Lu and C. Yu, Chem. Commun., 2018, 54, 2020 DOI: 10.1039/C8CC00327K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements